TickerFactsScreenerDevelopers

REGENEREX PHARMA, INC. (RGPX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$2.6K2018: -$49.5K2019: -$91.7K2020: -$77.0K2021: -$43.4K2022: -$126.3K2023: -$96.2K2024: -$3.47M2025: -$1.83M-$1.83M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$1.83M+47.3%
2024-$3.47M-3503.8%
2023-$96.2K+23.8%
2022-$126.3K-190.9%
2021-$43.4K+43.6%
2020-$77.0K+16.1%
2019-$91.7K-85.5%
2018-$49.5K-1821.9%
2017-$2.6K—